Magdalena Sobieszczyk

Columbia University - Aaron Diamond AIDS Research Center

Columbia University - Division of Infectious Diseases

United States

SCHOLARLY PAPERS

3

DOWNLOADS

135

TOTAL CITATIONS

0

Scholarly Papers (3)

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 32 Posted: 04 Jan 2022 Last Revised: 10 Jan 2022
Department of Neurology - Columbia University Irving Medical Center, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 70 (677,725)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, encephalopathy

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 28 Posted: 06 Jan 2022
Department of Neurology - Columbia University Irving Medical Center, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 18 (1,111,052)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, Encephalopathy

2.

Changes in Serum Neutralizing Antibody Potency and Breadth Post SARS-CoV-2 mRNA Vaccine Boost

Number of pages: 29 Posted: 29 Dec 2022
Columbia University - Aaron Diamond AIDS Research Center, Government of the United States of America - Theoretical Biology and Biophysics, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Aaron Diamond AIDS Research Center, Government of the United States of America - Theoretical Biology and Biophysics, Columbia University - Aaron Diamond AIDS Research Center and Columbia University - Aaron Diamond AIDS Research Center
Downloads 26 (984,068)

Abstract:

Loading...

Boosters, Vaccine sera, Neutralization breadth, Titer decay, Omicron, BA.5, BA.2.12.1, BA.1.1, Delta

3.

Fixed Dosing Versus Weight-Based Dosing of HIV-1 Prophylactic Monoclonal Antibodies in Adults: A Pharmacokinetics Modeling Study

Number of pages: 23 Posted: 14 Jan 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Family Health International, HPTN Leadership and Operations Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center, Harvard University - Brigham and Women’s Hospital, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Kelly Government Solutions, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Irving Medical Center, Emory University - School of Medicine, University of North Carolina (UNC) at Chapel Hill, Harvard University - Beth Israel Deaconess Medical Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Division of Infectious Diseases, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), George Washington University - School of Medicine and Health Sciences, National Institutes of Health, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, National Institutes of Health - Vaccine Research Center and Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology
Downloads 21 (1,099,816)

Abstract:

Loading...

HIV prevention, dosing strategy, exponent of body weight, two-compartment, population pharmacokinetics model, variability in exposure